TCM Biotech International Balance Sheet Health
Financial Health criteria checks 6/6
TCM Biotech International has a total shareholder equity of NT$1.0B and total debt of NT$107.2M, which brings its debt-to-equity ratio to 10.2%. Its total assets and total liabilities are NT$1.3B and NT$221.8M respectively. TCM Biotech International's EBIT is NT$26.4M making its interest coverage ratio -20.5. It has cash and short-term investments of NT$573.3M.
Key information
10.2%
Debt to equity ratio
NT$107.24m
Debt
| Interest coverage ratio | -20.5x |
| Cash | NT$573.32m |
| Equity | NT$1.05b |
| Total liabilities | NT$221.78m |
| Total assets | NT$1.27b |
Recent financial health updates
Recent updates
Can You Imagine How TCM Biotech International's (GTSM:4169) Shareholders Feel About The 28% Share Price Increase?
Jan 31
Key Things To Consider Before Buying TCM Biotech International Corp. (GTSM:4169) For Its Dividend
Jan 04We Think TCM Biotech International (GTSM:4169) Can Stay On Top Of Its Debt
Dec 07
Financial Position Analysis
Short Term Liabilities: 4169's short term assets (NT$924.0M) exceed its short term liabilities (NT$153.2M).
Long Term Liabilities: 4169's short term assets (NT$924.0M) exceed its long term liabilities (NT$68.6M).
Debt to Equity History and Analysis
Debt Level: 4169 has more cash than its total debt.
Reducing Debt: 4169's debt to equity ratio has reduced from 27.2% to 10.2% over the past 5 years.
Debt Coverage: 4169's debt is well covered by operating cash flow (46.9%).
Interest Coverage: 4169 earns more interest than it pays, so coverage of interest payments is not a concern.